Researchers have used radioimmunotherapy (RIT) to destroy remaining HIV-infected cells in the blood samples of patients treated with antiretroviral therapy, offering the promise of a strategy for curing HIV infection. Results of the study were presented at the Radiological Society of North America Annual Meeting (RSNA 2013).


Researchers have found that digital breast tomosynthesis (DBT) led to reduced recall rates and an increase in cancer detection in a large breast cancer screening program.


Automated breast density measurement is predictive of breast cancer risk in younger women, and that risk may be related to the rate at which breast density changes in some women as they age, according to research being presented at the Radiological Society of North America Annual Meeting (RSNA 2013).

Claron Technology has received Health Canada diagnostic approval for its NilRead zero-footprint medical image viewer. NilRead enables diagnostic interpretation of DICOM image files and related digital information anywhere and anytime on a diagnostic workstation and mobile devices when a workstation is not available. 

By Melinda Taschetta-Millane, editorial director

“The Power of Partnership” theme truly hits home with this year’s RSNA 2013 Scientific Assembly and Annual Meeting. Nearly everyone I have spoken with over the past two days has expressed this need to keep communication strong, cost-effective and efficient between the clinician and the patient.

Brit Systems Inc., an image management and IT solutions company, announced it is partnering with Radiolopolis, a global, online community for radiology professionals, to image enable the launch of Consult Me, a peer review consultation capability on the Radiolopolis Radiology Network.

BridgeHead Software, a healthcare data management developer, announced BridgeHead Deduplication for Backup and Recovery along with integrated support for HP StoreOnce Backup at the Radiological Society of North America Annual Meeting (RSNA 2013).

The New South Wales statewide image repository, powered by TeraMedica’s Evercore vendor neutral archive (VNA), has been recognized with the Australian Premier’s Award for Public Service.

 A new study reports that individuals who underwent embolization of the left gastric artery for gastrointestinal bleeding experienced a 7.9 percent decrease in body weight three months after the procedure. Results of the study, which offer a potential new avenue for obesity research, will be presented next week at the annual meeting of the Radiological Society of North America (RSNA).

Nanovi is developing products based on advanced biomaterials for use in the treatment of cancer. Nanovi’s first product (BioXmark) is an injectable tissue liquid marker, used to improve accuracy in the radiation treatment of patients with cancer. BioXmark has the potential to increase radiotherapy quality with minimal changes in today’s procedures and equipment. It will be available for commercial use in Europe around 2015 with clinical data to document its benefit.

Subscribe Now